Scott L. Friedman

95.6k citations

438 papers · 61.8k indexed · 38 hit papers · h-index 119

Impact in

Hepatology top 0.01%
- Liver physiology and pathology
- Liver Disease and Transplantation
- Liver Diseases and Immunity
- Hepatocellular Carcinoma Treatment and Prognosis
Epidemiology top 0.01%
- Liver Disease Diagnosis and Treatment

Papers in

Hepatology 243
- Liver physiology and pathology 180
- Liver Disease and Transplantation 49
- Liver Diseases and Immunity 34
Epidemiology 230
- Liver Disease Diagnosis and Treatment 220
- Hepatitis B Virus Studies 31

Co-authors: Takuma Tsuchida Virginia Hernández–Gea Arun J. Sanyal Josep M. Llovet Brent A. Neuschwander‐Tetri Mary E. Rinella Yujin Hoshida Augusto Villanueva
Journals: Hepatology (48 papers)Journal of Hepatology (38 papers)Gastroenterology (28 papers)Journal of Biological Chemistry (11 papers)Journal of Clinical Investigation (11 papers)
Partner nations: United States Spain Germany

In The Last Decade

Scott L. Friedman

427 papers receiving 60.9k citations

Hit Papers

15 papers align trajectories log scale

Friend or foe? The elusive role of hepatic stellate cells in liver cancer 2023 · 85 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Nature Reviews Gastroenterology & Hepatology
2023 Journal of Hepatology
2023 Nature Reviews Gastroenterology & Hepatology
2023 Science Translational Medicine
2021 Cell
2021 Hepatology
2020 Nature
2020 Cell Metabolism
2018 Journal of Hepatology
2018 Journal of Hepatology
2018 Nature Medicine
2017 Nature Reviews Gastroenterology & Hepatology
2017 Journal of Hepatology
2017 Advanced Drug Delivery Reviews
2017 Gastroenterology
2016 Gastroenterology
2015 Gut
2015 Gastroenterology
2015 Journal of Hepatology
2013 Comprehensive physiology
2013 Science Translational Medicine
2013 Gastroenterology
2013 Autophagy
2012 Gastroenterology
2011 Best Practice & Research Clinical Gastroenterology
2011 Annual Review of Pathology Mechanisms of Disease
2010 Nature Reviews Gastroenterology & Hepatology
2009 Cancer Research
2008 Physiological Reviews
2008 Gastroenterology
2007 Hepatology
2003 Journal of Hepatology
2000 Journal of Biological Chemistry
1998 The Journal of Experimental Medicine
1995 Physical review. B, Condensed matter
1994 Physical Review Letters
1993 New England Journal of Medicine
1985 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Scott L. Friedman

Since Specialization

Citations

This map shows the geographic impact of Scott L. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott L. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott L. Friedman more than expected).

Fields of papers citing papers by Scott L. Friedman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott L. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott L. Friedman. The network helps show where Scott L. Friedman may publish in the future.

Co-authors

The 25 scholars most cited alongside Scott L. Friedman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Scott L. Friedman Line = papers co-authored together Scott L. Friedman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Resolvin D1-mediated cellular crosstalk protects against MASH JHEP Reports ·Amaia Navarro‐Corcuera, Yiwei Zhu, Fanglin Ma, Neha Gupta, Haley Asplund, Bruno Cogliati, Jerry E. Chipuk, Oren Rom, Scott L. Friedman, Brian E. Sansbury, Xin Huang, Bishuang Cai	2025	2
2	Addressing the High and Rising Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction‐Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective Alimentary Pharmacology & Therapeutics ·Zobair M. Younossi, Homie Razavi, Michael S. Sherman, Alina M. Allen, Quentin M. Anstee, Kenneth Cusi, Scott L. Friedman, Eric Lawitz, Jeffrey V. Lazarus, Detlef Schuppan, Manuel Romero‐Gómez, Jörn M. Schattenberg, Miriam B. Vos, Vincent Wai‐Sun Wong, Vlad Ratziu, Marcus Hompesch, Arun J. Sanyal, Rohit Loomba	2025	8
3	Kisspeptin Alleviates Human Hepatic Fibrogenesis by Inhibiting TGFβ Signaling in Hepatic Stellate Cells Cells ·Kavita Prasad, Dipankar Bhattacharya, Shams Gamal Eldin Shams, Kimberly Izarraras, Tia Hart, Brent Mayfield, Maryjka B. Blaszczyk, Zhongren Zhou, Utpal B. Pajvani, Scott L. Friedman, Moshmi Bhattacharya	2024	1
4	Secreted folate receptor γ drives fibrogenesis in metabolic dysfunction–associated steatohepatitis by amplifying TGFβ signaling in hepatic stellate cells Science Translational Medicine ·Connor Quinn, Mario C. Rico, Carmen Merali, Carlos A. Barrero, Óscar Cano Pérez, Victoria Mischley, John Karanicolas, Scott L. Friedman, Salim Merali	2023	11
5	Genetic Characterization of Rat Hepatic Stellate Cell Line HSC-T6 for In Vitro Cell Line Authentication Cells ·Indrajit Nanda, Claus Steinlein, Thomas Haaf, Eva Miriam Buhl, Dominik G. Grimm, Scott L. Friedman, Steffen K. Meurer, Sarah K. Schröder, Ralf Weiskirchen	2022	15
6	Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma Hepatology ·Laura Torrens, Carla Montironi, Marc Puigvehí, Agavni Mesropian, Jack Leslie, Philipp K. Haber, Miho Maeda, Ugne Balaseviciute, Catherine E. Willoughby, Jordi Abril‐Fornaguera, Marta Piqué‐Gili, Miguel Torres‐Martín, Judit Peix, Daniel Geh, Erik Ramon‐Gil, Behnam Saberi, Scott L. Friedman, Derek A. Mann, Daniela Sia, Josep M. Llovet	2021	107
7	MRI is the most commonly used imaging modality for HCC screening at a tertiary care transplant center Abdominal Radiology ·Gabriela Hernandez‐Meza, Naïk Vietti Violi, Daniela Said, Eitan Novogrodsky, Dillan F. Villavisanis, Samuel Z. Maron, Justin J. Frere, Thomas D. Schiano, Scott L. Friedman, Paolo Boffetta, Andrea D. Branch, Bachir Taouli	2021	5
8	Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population Journal of Hepatology ·Mette Juul Nielsen, Diana Julie Leeming, Zachary Goodman, Scott L. Friedman, Peder Frederiksen, Daniel Guldager Kring Rasmussen, Pamela Vig, Star Seyedkazemi, Laurent Fischer, Richard Torstenson, M.A. Karsdal, Éric Lefebvre, Arun J. Sanyal, Vlad Ratziu	2021	42
9	Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative Liver International ·Geurt Stokman, Anita M. van den Hoek, Ditte Denker Thorbekk, Elsbet Pieterman, Sanne Skovgård Veidal, Brittany Basta, Marta Iruarrizaga‐Lejarreta, José W. van der Hoorn, Lars Verschuren, Jimmy F.P. Berbée, Patrick C.N. Rensen, Tore Skjæret, Cristina Alonso, Michael Feigh, John J.P. Kastelein, Scott L. Friedman, P. Hans, David A. Fraser	2020	15
10	SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis Scientific Reports ·Varinder Athwal, James Pritchett, Katherine J. Martin, Jessica Llewellyn, Jennifer A. Scott, Emma Harvey, Abed M. Zaitoun, Aoibheann Mullan, Leo Zeef, Scott L. Friedman, William L. Irving, Neil A. Hanley, Indra Neil Guha, Karen Piper Hanley	2018	37
11	Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features Gastroenterology ·Daniela Sia, Yang Jiao, Iris Martinez-Quetglas, Olga Kuchuk, Carlos Villacorta-Martín, Manuel Castro de Moura, Juan Putra, Genís Campreciós, Laia Bassaganyas, Nicholas K. Akers, Bojan Losic, Samuel Waxman, Swan N. Thung, Vincenzo Mazzaferro, Manel Esteller, Scott L. Friedman, M. Schwartz, Augusto Villanueva, Josep M. Llovet Hit paper breakdown →	2017	632
12	Pathobiology of liver fibrosis: a translational success story Gut ·Youngmin A. Lee, M. Christopher Wallace, Scott L. Friedman Hit paper breakdown →	2015	698
13	Functions of autophagy in normal and diseased liver Autophagy ·Mark J. Czaja, Wen-Xing Ding, Terrence M. Donohue, Scott L. Friedman, Kim Js, Masaaki Komatsu, John J. Lemasters, Antoinette Lemoine, Jiandie D. Lin, Jing‐hsiung James Ou, David H. Perlmutter, Glenn Randall, Ratna B. Ray, Allan Tsung, Xiao-Ming Yin Hit paper breakdown →	2013	373
14	Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib Clinical Cancer Research ·Anja Lachenmayer, Clara Alsinet, Radoslav Savić, Laia Cabellos, Sara Toffanin, Yujin Hoshida, Augusto Villanueva, Beatriz Mínguez, Philippa Newell, Hung‐Wen Tsai, Jordi Barretina, Swan N. Thung, Stephen C. Ward, Jordi Bruix, Vincenzo Mazzaferro, Myron Schwartz, Scott L. Friedman, Josep M. Llovet	2012	230
15	Detection of a secreted metalloprotease within the nuclei of liver cells Molecular BioSystems ·Ryan Hunt, S. Geetha, Courtni E. Allen, Klilah Hershko, Robert Fathke, Philip Kong, Elizabeth Plum, Evi Struble, Kenji Soejima, Scott L. Friedman, Susan H. Garfield, Balaji Santhanam, Chava Kimchi‐Sarfaty	2011	5
16	MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a Gastroenterology ·Sara Toffanin, Yujin Hoshida, Anja Lachenmayer, Augusto Villanueva, Laia Cabellos, Beatriz Mínguez, Radoslav Savić, Stephen C. Ward, Swan N. Thung, Derek Y. Chiang, Clara Alsinet, Victoria Tovar, Sasan Roayaie, Myron Schwartz, Jordi Bruix, Samuel Waxman, Scott L. Friedman, Todd R. Golub, Vincenzo Mazzaferro, Josep M. Llovet	2011	171
17	Artemisia capillaris Thunb. inhibits cell growth and induces apoptosis in human hepatic stellate cell line LX2 Oriental Pharmacy and Experimental Medicine ·Young‐Il Kim, Lee Jang-Hoon, Seung Won Park, In-Hwa Choi, Scott L. Friedman, 우홍정, Youngchul Kim	2010	1
18	Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma Cancer Research ·Yujin Hoshida, Sebastian Nijman, Masahiro Kobayashi, Jennifer A. Chan, Jean-Philippe Brunet, Derek Y. Chiang, Augusto Villanueva, Philippa Newell, Kenji Ikeda, Masaji Hashimoto, Goro Watanabe, Stacey Gabriel, Scott L. Friedman, Hiromitsu Kumada, Josep M. Llovet, Todd R. Golub Hit paper breakdown →	2009	872
19	Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma† Hepatology ·Elisa Wurmbach, Ying‐Bei Chen, Greg Khitrov, Weijia Zhang, Sasan Roayaie, Myron Schwartz, Isabel Fiel, Swan N. Thung, Vincenzo Mazzaferro, Jordi Bruix, Erwin P. Böttinger, Scott L. Friedman, Samuel Waxman, Josep M. Llovet Hit paper breakdown →	2007	559
20	Dysregulation of hedgehog pathway signaling in hepatocellular carcinoma Cancer Research ·Eric R. Lemmer, Ying‐Bei Chen, Steven Yea, Elisa Wurmbach, Myron Schwartz, Gregory Khitrov, Augusto Villanueva, Goutham Narla, Samuel Waxman, Scott L. Friedman, Josep M. Llovet	2006	0

About Scott L. Friedman

Scott L. Friedman is a scholar working on Hepatology, Epidemiology, Cell Biology, Pathology and Forensic Medicine and Immunology, having authored 438 papers that have together received 61.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (220 papers), Liver physiology and pathology (180 papers), Kruppel-like factors research (52 papers), Liver Disease and Transplantation (49 papers), Cancer-related gene regulation (37 papers), Liver Diseases and Immunity (34 papers), Endoplasmic Reticulum Stress and Disease (33 papers) and Hepatitis B Virus Studies (31 papers). The work is most often cited by research in Hepatology (30.7k citations), Epidemiology (32.5k citations), Pharmacology (3.3k citations), Cancer Research (5.7k citations) and Cell Biology (5.7k citations). Scott L. Friedman has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Takuma Tsuchida, Virginia Hernández–Gea, Arun J. Sanyal, Josep M. Llovet, Brent A. Neuschwander‐Tetri, Mary E. Rinella, Yujin Hoshida, Augusto Villanueva, F J Roll and Rohit Loomba. Their work appears in journals such as Hepatology, Journal of Hepatology, Gastroenterology, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact